Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]
A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment [NA]
Clinical trial update from Umeå University studying local radiotherapy for bladder cancer in patients not eligible for curative treatment; t…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder [Phase 3]
Phase 3 study evaluating TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy for muscle-invasive bladder cancer; the …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Virtuoso Improving Anatomic Bladder Lesion Excision Trial [NA]
This document provides a status update that the Virtuoso Improving Anatomic Bladder Lesion Excision Trial is currently enrolling by invitati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy [Phase 2]
Phase 2 clinical trial evaluating the effectiveness and safety of sequential intravesical mitomycin-C and gemcitabine for bladder cancer; cu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas [Phase 1]
Phase 1 study evaluating safety, efficacy, and pharmacokinetics of EVOLVE104 in patients with advanced urothelial cancer and squamous cell c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer [NA]
This clinical trial examines using FAPI and FDG PET/MRI imaging to diagnose bladder cancer and predict response to therapy.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
A ClinicalTrials.gov entry describes a study evaluating the immune-stromal landscape in muscle-invasive bladder cancer, sponsored by Assiut …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes [Phase 2]
A Phase 2 clinical trial evaluating olaparib for advanced or metastatic bladder cancer and other genitourinary tumors with DNA-repair gene c…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer
This entry notes a clinical trial (NCT07511517) evaluating the BladMetrix urine test to monitor recurrence in non-muscle invasive bladder ca…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating two dosing schedules of atezolizumab in combination with gemcitabine and cisplatin as first-line therapy for metast…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Determinants of Bladder Cancer Recurrence Study (The DETER Study)
The DETER Study, sponsored by Memorial Sloan Kettering Cancer Center, investigates determinants of bladder cancer recurrence and is currentl…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Bladder EpiCheck Product Development Study
This clinical trial update indicates that Nucleix Ltd.'s Bladder EpiCheck product development study is currently recruiting to evaluate its …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
A clinical trial is recruiting to evaluate measuring CREPT protein levels in urine as a noninvasive method to diagnose and monitor bladder c…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy [Phase 2]
A Phase 2 clinical trial evaluating treatment for metastatic bladder cancer at the time of biochemical relapse after radical cystectomy; the…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients [NA]
This clinical trial update reports on germline alterations of tumor susceptibility genes in New York cancer patients across multiple cancer …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) [Phase 2]
A Phase 2 study of Intismeran Autogene (V940) in combination with BCG for bladder cancer is currently recruiting, targeting non-muscle-invas…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 trial evaluating nivolumab with and without urelumab in cisplatin-ineligible or chemotherapy-refusing patients with muscle-invasive …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
This ClinicalTrials.gov entry describes the NCI-sponsored study NCT02379429, a trial focusing on care of urothelial cancer patients and pros…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Clinical trial update noting ongoing recruitment for a study evaluating AI-enabled blue light enhanced cystoscopy for detecting bladder canc…